Stockreport

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition [Yahoo! Finance]

Catalent, Inc.  (CTLT) 
Last catalent, inc. earnings: 2/3 07:30 am Check Earnings Report
US:NYSE Investor Relations: investor.catalent.com
PDF Sales increased 9% year over year to 15.14 billion Swiss francs (~$17.5 billion). The company's pharmaceuticals division reported sales of 11.62 billion Swiss francs. [Read more]